Tesla stock hasn't been this oversold in more than a year
A brutal year for Tesla (TSLA) investors is getting even more brutal.
Quick insight: The post-earnings slide in Tesla stock has made it the most oversold since March 2025, according to Yahoo Finance AlphaSpace data. Overbought and oversold levels for a stock are tracked by the relative strength index,
» Read more about: Tesla stock hasn't been this oversold in more than a year »
Read MoreWhy are tech stocks tanking?
Investor jitters over how long the artificial intelligence spending boom will last and concern over Chinese competition in chipmaking sent technology shares plunging Tuesday.
South Korea’s Samsung Electronics fell more than 12 percent and Japanese memory chipmaker Kioxia was down 18 percent,
» Read more about: Why are tech stocks tanking? »
Read MoreSector Update: Tech Stocks Fall Pre-Bell Tuesday
Technology stocks were falling pre-bell Tuesday, with the State Street Technology Select Sector SPDR
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.
» Read more about: Sector Update: Tech Stocks Fall Pre-Bell Tuesday »
Read MoreInvesting $500 per Month in This ETF Could Set You Up for Life, According to History
Warren Buffett was right when he said, “There seems to be some perverse human characteristic that likes to make easy things difficult.” Too many investors are constantly hunting for the next great growth stock, only to suffer avoidable setbacks by owning the wrong risky stocks. These people could do at least as well —
Will Generic Drug Tariffs Impact Pharma ETFs?
U.S. President Donald Trump’s recently proposed tariffs on imported generic drugs aim to encourage domestic drug manufacturing and are expected to increase costs in the near future for generic drugs, which are imported into the United States.
Trump announced on July 21, 2026, that imported generic medicines will remain tariff-free for two years beginning Aug.
» Read more about: Will Generic Drug Tariffs Impact Pharma ETFs? »
Read MoreThe Burst
3 Dividend Stocks Worth Buying Now?
Thanks to surging stock prices over the past two years, dividend yields on major stock indices have fallen to fairly low levels. The S&P 500, for instance, currently carries an average yield of just 1.3%.
The mature companies in the Dow Jones Industrial Average fare a bit better, and some of them offer yields that exceed the S&P 500 several times over.
» Read more about: 3 Dividend Stocks Worth Buying Now? »
Read MoreThe Ivy
Why This Stock Could Be a Dividend Powerhouse for the Next Decade
Brookfield Renewable (NYSE: BEPC, BEP) doesn’t just participate in the energy transition but profits from it in ways few investors fully appreciate.
While many renewable stocks have stumbled in the face of rising rates and public market disinterest, Brookfield’s long-term game plan is quietly delivering results. One of the clearest signs? The dividend streak is 10 years.
» Read more about: Why This Stock Could Be a Dividend Powerhouse for the Next Decade »
Read MoreThe Spotlight
1 Stock That Will Pay You Monthly
When Charlie Munger was a boy, he described an encounter he had with an older man who seemed to work very little but had a lot of money. Curious what the man did he questioned the line of business he was in and discovered to his surprise he “rendered dead horses.” What Charlie learned from the conversation was less about horses and more about how one man got rich because he was the only player in that market.